Monica Bertagnolli

Became the 17th Director of the NIH in November 2023. She Is the First Surgeon and Second Woman to Hold the Position. · University at Buffalo School of Medicine

Credentials: · · ·

History

NIH in November 2023. She is the first surgeon and second woman to hold the position. · University at Buffalo School of Medicine
Present

Surgery
1985–1990
University of Utah School of Medicine
1981–1985

Research

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Science · 2016 · 3,807 citations
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
New England Journal of Medicine · 2005 · 1,632 citations
Molecular origins of cancer: Molecular basis of colorectal cancer
Review · New England Journal of Medicine · 2009 · 1,444 citations

Robert Mayer
25 papers
Alan Venook
21 papers
RG
Richard Goldberg
21 papers
Chandrajit Raut
20 papers
MR
Mark Redston
17 papers
CC
Carolyn Compton
14 papers
Robert Warren
14 papers
Heinz-Josef Lenz
13 papers
LS
Leonard Saltz
13 papers
Jeffrey Meyerhardt
12 papers
Jiping Wang
12 papers
Suzanne George
12 papers · 1 as a fellow

Grants

Alliance NCORP Research Base
National Cancer Institute · UG1
Contact PI · $17.2M · Alliance Nctn Foundation
2014–2025
Alliance for Clinical Trials in Oncology Operations Center
National Cancer Institute · U10
Contact PI · $124M · Alliance Nctn Foundation
2014–2025
Advanced Training in Surgical Oncology
National Cancer Institute · T32
Contact PI · $1.1M · Brigham and Women's Hospital
1985–2016
Cancer and Leukemia Group B CCOP Research Base
National Cancer Institute · U10
Contact PI · $10.8M · Brigham and Women's Hospital
1983–2016

Clinical trials

Atezolizumab Immunotherapy in Patients With Advanced NSCLC
Principal investigator · Completed · Phase 2
Alliance Foundation Trials, LLC.
2017–2022
Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
Principal investigator · Completed · Phase 3
National Cancer Institute (NCI)
2000
Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581
Study chair · Completed
Alliance for Clinical Trials in Oncology
2007–2019
Genetic Study of Familial Factors in Patients With Colon Cancer
Study chair · Completed
Alliance for Clinical Trials in Oncology
2001–2010